InsidersTradesSigma
Track the Novacyt S.A. stock price and the full directors' dealings record of the company, a publicly traded company based in United Kingdom. Shares trade on the UK market, under the authority of RNS (LSE). Market capitalisation: €27.1m. The latest transaction was filed on 30 March 2026 (Purchase). Among the most active insiders: 1) CEO 2) Chairman 3) NED. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Novacyt S.A. es una empresa de biotecnología centrada en el desarrollo de pruebas de diagnóstico para enfermedades infecciosas. Cotiza en el mercado de Londres bajo el ticker XLON.